Credit Suisse’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,094
| Closed | -$115K | – | 3569 |
|
|
2021
Q1 | $115K | Sell |
2,094
-824
| -28% | -$45.3K | ﹤0.01% | 3329 |
|
|
2020
Q4 | $212K | Sell |
2,918
-860
| -23% | -$62.5K | ﹤0.01% | 3226 |
|
|
2020
Q3 | $746K | Sell |
3,778
-1,206
| -24% | -$238K | ﹤0.01% | 2454 |
|
|
2020
Q2 | $1.4M | Buy |
4,984
+2,721
| +120% | +$762K | ﹤0.01% | 2110 |
|
|
2020
Q1 | $402K | Buy |
2,263
+959
| +74% | +$170K | ﹤0.01% | 2647 |
|
|
2019
Q4 | $321K | Buy |
1,304
+126
| +11% | +$31K | ﹤0.01% | 3133 |
|
|
2019
Q3 | $139K | Sell |
1,178
-349
| -23% | -$41.2K | ﹤0.01% | 3257 |
|
|
2019
Q2 | $246K | Buy |
1,527
+318
| +26% | +$51.2K | ﹤0.01% | 3130 |
|
|
2019
Q1 | $286K | Sell |
1,209
-101
| -8% | -$23.9K | ﹤0.01% | 3039 |
|
|
2018
Q4 | $356K | Buy |
1,310
+183
| +16% | +$49.7K | ﹤0.01% | 2914 |
|
|
2018
Q3 | $502K | Sell |
1,127
-434
| -28% | -$193K | ﹤0.01% | 2833 |
|
|
2018
Q2 | $734K | Sell |
1,561
-283
| -15% | -$133K | ﹤0.01% | 2782 |
|
|
2018
Q1 | $1.09M | Buy |
1,844
+687
| +59% | +$405K | ﹤0.01% | 2513 |
|
|
2017
Q4 | $628K | Buy |
1,157
+257
| +29% | +$139K | ﹤0.01% | 2827 |
|
|
2017
Q3 | $377K | Buy |
+900
| New | +$377K | ﹤0.01% | 3155 |
|
|
2016
Q4 | – | Sell |
-1,255
| Closed | -$109K | – | 3714 |
|
|
2016
Q3 | $109K | Sell |
1,255
-2,844
| -69% | -$247K | ﹤0.01% | 3573 |
|
|
2016
Q2 | $273K | Buy |
4,099
+3,228
| +371% | +$215K | ﹤0.01% | 3433 |
|
|
2016
Q1 | $52K | Buy |
871
+32
| +4% | +$1.91K | ﹤0.01% | 3584 |
|
|
2015
Q4 | $76K | Buy |
+839
| New | +$76K | ﹤0.01% | 3869 |
|
|
2015
Q3 | – | Sell |
-1,026
| Closed | -$237K | – | 4025 |
|
|
2015
Q2 | $237K | Buy |
+1,026
| New | +$237K | ﹤0.01% | 3849 |
|